Abstract
Liu et al. isolated 50 escape mutants to 19 monoclonal antibodies targeting the SARS-CoV-2 spike using a VSV-SARS2 chimera. Some mutants (S477N) resist neutralization by multiple mAbs, and others (E484K) are less sensitive to neutralization by convalescent sera. Several mutants exist in clinical SARS2-CoV-2 isolates and thus warrant further study.
| Original language | English |
|---|---|
| Pages (from-to) | 477-488.e4 |
| Journal | Cell Host and Microbe |
| Volume | 29 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 10 2021 |
Keywords
- ACE2 receptor decoys
- COVID-19 vaccines
- SARS-CoV-2 escape mutants
- convalescent sera
- coronaviruses
- monoclonal antibodies
- receptor-binding domain
Fingerprint
Dive into the research topics of 'Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver